JP2017515888A5 - - Google Patents

Download PDF

Info

Publication number
JP2017515888A5
JP2017515888A5 JP2017502766A JP2017502766A JP2017515888A5 JP 2017515888 A5 JP2017515888 A5 JP 2017515888A5 JP 2017502766 A JP2017502766 A JP 2017502766A JP 2017502766 A JP2017502766 A JP 2017502766A JP 2017515888 A5 JP2017515888 A5 JP 2017515888A5
Authority
JP
Japan
Prior art keywords
composition
shock
polyethylene glycol
electrolytes
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017502766A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017515888A (ja
JP6648106B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/022198 external-priority patent/WO2015148474A1/en
Publication of JP2017515888A publication Critical patent/JP2017515888A/ja
Publication of JP2017515888A5 publication Critical patent/JP2017515888A5/ja
Application granted granted Critical
Publication of JP6648106B2 publication Critical patent/JP6648106B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017502766A 2014-03-25 2015-03-24 自己消化の治療用組成物 Expired - Fee Related JP6648106B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461970247P 2014-03-25 2014-03-25
US61/970,247 2014-03-25
US201462019007P 2014-06-30 2014-06-30
US62/019,007 2014-06-30
PCT/US2015/022198 WO2015148474A1 (en) 2014-03-25 2015-03-24 Compositions for the treatment of autodigestion

Publications (3)

Publication Number Publication Date
JP2017515888A JP2017515888A (ja) 2017-06-15
JP2017515888A5 true JP2017515888A5 (https=) 2018-05-10
JP6648106B2 JP6648106B2 (ja) 2020-02-14

Family

ID=54188811

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017502766A Expired - Fee Related JP6648106B2 (ja) 2014-03-25 2015-03-24 自己消化の治療用組成物

Country Status (14)

Country Link
US (4) US9314442B2 (https=)
EP (1) EP3122349B1 (https=)
JP (1) JP6648106B2 (https=)
KR (2) KR20220068266A (https=)
CN (3) CN112807325A (https=)
AU (1) AU2015236283B2 (https=)
CA (1) CA2942358C (https=)
DK (1) DK3122349T3 (https=)
ES (1) ES2906262T3 (https=)
MX (1) MX376176B (https=)
PL (1) PL3122349T3 (https=)
PT (1) PT3122349T (https=)
TW (2) TWI554269B (https=)
WO (1) WO2015148474A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504736B2 (en) 2010-09-23 2016-11-29 The Regents Of The University Of California Administration of serine protease inhibitors to the stomach
CN112807325A (zh) 2014-03-25 2021-05-18 恒翼生物医药科技(上海)有限公司 用于治疗自身消化的组合物
CA3010986A1 (en) 2016-01-11 2017-07-20 Leading BioSciences, Inc. Compositions and methods for treating and preventing adhesions and ileus
US20200323803A1 (en) * 2017-10-24 2020-10-15 Leading BioSciences, Inc. Compositions and methods for glucose control
US11666532B2 (en) 2018-01-19 2023-06-06 Hyloris Developments Sa Tranexamic acid oral solution
CN110730413A (zh) * 2018-06-29 2020-01-24 阿里巴巴集团控股有限公司 一种终端定位方法和装置
US10980757B2 (en) 2018-09-06 2021-04-20 RTU Pharma SA Ready-to-use tranexamic acid intravenous solution

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56158707A (en) * 1980-04-08 1981-12-07 Lion Corp Composition for oral use
JP3496158B2 (ja) 1993-01-26 2004-02-09 東洋カプセル株式会社 トラネキサム酸配合ゼラチンカプセル製剤
US5578568A (en) 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
DE19617369A1 (de) 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
JP3940209B2 (ja) 1996-11-14 2007-07-04 株式会社資生堂 可溶化化粧料
US6121232A (en) 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
CA2301921A1 (en) 1997-08-20 1999-02-25 John Graham Goddard Compositions containing polyethylene glycol and uses thereof
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
DE10025001A1 (de) 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
AU1794801A (en) 1999-11-24 2001-06-04 Regents Of The University Of California, The Method for treatment and prevention of physiological shock
US6708822B1 (en) 1999-11-30 2004-03-23 Cutispharma, Inc. Compositions and kits for compounding pharmaceuticals
US20030144212A1 (en) 2000-07-06 2003-07-31 Hoffman Keith B Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host
JP4044748B2 (ja) 2001-10-17 2008-02-06 サンスター株式会社 口腔用液体組成物
US20040018984A1 (en) 2002-07-17 2004-01-29 Mizuo Miyazaki Methods for preventing adhesion formation using protease inhibitors
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
JP5271475B2 (ja) 2002-11-26 2013-08-21 ザ ユニヴァーシティー オヴ シカゴ 微生物媒介上皮疾患の予防及び治療のための材料並びに方法
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
JP2005068076A (ja) 2003-08-25 2005-03-17 Tendou Seiyaku Kk トラネキサム酸類を含む外用液剤および清拭剤
US20090215898A1 (en) 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
EP1744767A4 (en) 2004-04-20 2008-08-13 Univ Chicago THERAPEUTIC DELIVERY SYSTEM WITH PEG-LIKE CONNECTION WITH HIGH MOLECULAR WEIGHT
CA2610951A1 (en) 2005-06-03 2006-12-14 The University Of Chicago Modulation of microbial pathogen-host cell interactions
CA2609985A1 (en) 2005-06-03 2007-05-10 The University Of Chicago Modulation of cell barrier dysfunction
US20080194611A1 (en) 2005-06-03 2008-08-14 Alverdy John C Modulation of Cell Barrier Dysfunction
WO2007101264A2 (en) 2006-02-28 2007-09-07 The University Of Chicago Method for treating endothelial and epithelial cell disorders by administering high molecular weight peg-like compounds
JP5465824B2 (ja) 2006-03-24 2014-04-09 第一三共ヘルスケア株式会社 医薬用製剤およびその製造方法
US20100179091A1 (en) 2007-02-20 2010-07-15 The Regents Of The University Of California Treatment of Conditions Related to Shock
US8252302B2 (en) 2007-06-11 2012-08-28 Edge Therapeutics, Inc. Methods and compositions to treat hemorrhagic conditions of the brain
JP5093841B2 (ja) 2007-07-12 2012-12-12 株式会社 資生堂 不織布含浸化粧料
US9272034B2 (en) 2007-10-04 2016-03-01 The Regents Of The University Of California Treatment of conditions related to shock
WO2010087874A1 (en) 2009-01-28 2010-08-05 Anazyme, Llc Compositions and methods for diagnosis of shock
WO2009132149A2 (en) 2008-04-22 2009-10-29 The Regents Of The University Of California Treatment of conditions related to cecal ligation shock
WO2009137672A1 (en) 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
US7635707B1 (en) * 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
ZA201107285B (en) 2009-03-06 2012-12-27 Delivtx Inc Microencapsulated bioactive agents for oral delivery and methods of the thereof
MX2011009988A (es) 2009-03-23 2011-11-18 Univ Chicago Metodos para la prevencion y el tratamiento de trastornos epiteliales inducidos por radiaciones.
US8852155B2 (en) * 2009-08-12 2014-10-07 Medimetrics Personalized Drug Delivery Medicine reservoir for drug delivery device
WO2011028234A1 (en) 2009-09-04 2011-03-10 Xenoport, Inc. Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid
US9504736B2 (en) * 2010-09-23 2016-11-29 The Regents Of The University Of California Administration of serine protease inhibitors to the stomach
CN103237558A (zh) 2010-10-02 2013-08-07 加利福尼亚大学董事会 最小化肠功能障碍
JP6148454B2 (ja) * 2011-11-11 2017-06-14 ロート製薬株式会社 トラネキサム酸を含む外用及び内服用組成物
ES2375784B1 (es) 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
CN103565743B (zh) * 2012-07-23 2016-06-22 上海市徐汇区中心医院 氨甲环酸皮肤外用纳米制剂及其制备方法和用途
US9937199B2 (en) 2012-08-17 2018-04-10 The University Of Chicago Materials and methods for preventing and treating anastomotic leaks
CN103054861A (zh) * 2012-12-29 2013-04-24 北京阜康仁生物制药科技有限公司 一种含氨甲环酸的复方固体制剂
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
CN112807325A (zh) 2014-03-25 2021-05-18 恒翼生物医药科技(上海)有限公司 用于治疗自身消化的组合物
US20150297619A1 (en) 2014-04-17 2015-10-22 The Regents Of The University Of California Methods and compositions for preserving the mucosal barrier

Similar Documents

Publication Publication Date Title
JP2017515888A5 (https=)
JP2013518107A5 (https=)
JP2017537066A5 (https=)
JP2018530592A5 (https=)
HRP20180007T1 (hr) Formulacija koja sadrži gemcitabin-predlijek
RU2018114447A (ru) Введение дейтерированных усилителей cftr
JP2016510326A5 (https=)
HRP20240168T1 (hr) Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
RU2010114033A (ru) Применение ингибитора nf-каппа в sn50 и необязательно ангиотензина iii в качестве терапевтических средств при лечении, например, инфекции hbv
JP2008001724A5 (https=)
JP2013518056A5 (https=)
JP2015529234A5 (https=)
RU2013138672A (ru) Способ, композиция и набор для чистки кишечника
JP2016512210A5 (https=)
JP2015500702A5 (https=)
JP2016511753A5 (https=)
FI3817751T3 (fi) Vedettömän natriumtiosulfaatin formulaatioita
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
JP2016529306A5 (https=)
JP6648106B2 (ja) 自己消化の治療用組成物
RU2016138577A (ru) Жидкая фармцевтическая композиция
JP2017105861A5 (https=)
HRP20210010T1 (hr) Injekcijske farmaceutske formulacije lefamulina
JP2021513521A5 (https=)
RU2008111148A (ru) Применение комплексных соединений железа (iii) для производства лекарственного средства для перорального лечения железодефицитных состояний у больных, страдающих хроническими воспалительными заболеваниями кишечника